Mantsou Aglaia, Papachristou Eleni, Keramidas Panagiotis, Lamprou Paraskevas, Pitou Maria, Papi Rigini M, Dimitriou Katerina, Aggeli Amalia, Choli-Papadopoulou Theodora
Laboratory of Biochemistry, School of Chemistry, Faculty of Sciences, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Laboratory of Chemical Engineering A', School of Chemical Engineering, Faculty of Engineering, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Biomedicines. 2023 Jul 3;11(7):1890. doi: 10.3390/biomedicines11071890.
The regeneration of articular cartilage remains a serious problem in various pathological conditions such as osteoarthritis, due to the tissue's low self-healing capacity. The latest therapeutic approaches focus on the construction of biomaterials that induce cartilage repair. This research describes the design, synthesis, and investigation of a safe, "smart", fibrous scaffold containing a genetically incorporated active peptide for chondrogenic induction. While possessing specific sequences and the respective mechanical properties from natural fibrous proteins, the fibers also incorporate a Transforming Growth Factor-β1 (TGF-β1)-derived peptide (YYVGRKPK) that can promote chondrogenesis. The scaffold formed stable porous networks with shear-thinning properties at 37 °C, as shown by SEM imaging and rheological characterization, and were proven to be non-toxic to human dental pulp stem cells (hDPSCs). Its chondrogenic capacity was evidenced by a strong increase in the expression of specific chondrogenesis gene markers , , , and in cells cultured on "scaffold-TGFβ1" for 21 days and by increased phosphorylation of intracellular signaling proteins Smad-2 and Erk-1/2. Additionally, intense staining of glycosaminoglycans was observed in these cells. According to our results, "scaffold-TGFβ1" is proposed for clinical studies as a safe, injectable treatment for cartilage degeneration.
由于关节软骨组织的自我修复能力较低,在骨关节炎等各种病理状况下,关节软骨的再生仍然是一个严重问题。最新的治疗方法聚焦于构建可诱导软骨修复的生物材料。本研究描述了一种安全、“智能”的纤维支架的设计、合成及研究,该支架含有基因整合的用于软骨生成诱导的活性肽。这些纤维虽然具有天然纤维蛋白的特定序列和相应机械性能,但还整合了一种可促进软骨生成的源自转化生长因子-β1(TGF-β1)的肽(YYVGRKPK)。如扫描电子显微镜成像和流变学表征所示,该支架在37℃时形成了具有剪切变稀特性的稳定多孔网络,并且已证明对人牙髓干细胞(hDPSC)无毒。在“支架-TGFβ1”上培养21天的细胞中,特定软骨生成基因标记物 、 、 、 和 的表达显著增加,以及细胞内信号蛋白Smad-2和Erk-1/2的磷酸化增加,证明了其软骨生成能力。此外,在这些细胞中观察到糖胺聚糖的强烈染色。根据我们的结果,“支架-TGFβ1”被提议作为一种安全的、可注射的治疗软骨退变的方法用于临床研究。